Gerard M. McGeehan

6.0k total citations
60 papers, 2.1k citations indexed

About

Gerard M. McGeehan is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Gerard M. McGeehan has authored 60 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 19 papers in Hematology and 13 papers in Oncology. Recurrent topics in Gerard M. McGeehan's work include Acute Myeloid Leukemia Research (15 papers), Protein Degradation and Inhibitors (15 papers) and Protease and Inhibitor Mechanisms (10 papers). Gerard M. McGeehan is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Protein Degradation and Inhibitors (15 papers) and Protease and Inhibitor Mechanisms (10 papers). Gerard M. McGeehan collaborates with scholars based in United States, United Kingdom and Germany. Gerard M. McGeehan's co-authors include Michael C. Pirrung, Andrew B. McElroy, J. David Becherer, Frank J. Schoenen, Janet Warner, D. Mark Bickett, James G. Conway, James Nichols, Michael Luther and Les Sekut and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

Gerard M. McGeehan

57 papers receiving 2.1k citations

Peers

Countries citing papers authored by Gerard M. McGeehan

Since Specialization

Citations

This map shows the geographic impact of Gerard M. McGeehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard M. McGeehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard M. McGeehan more than expected).

Fields of papers citing papers by Gerard M. McGeehan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard M. McGeehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard M. McGeehan. The network helps show where Gerard M. McGeehan may publish in the future.

Co-authorship network of co-authors of Gerard M. McGeehan

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard M. McGeehan. A scholar is included among the top collaborators of Gerard M. McGeehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard M. McGeehan. Gerard M. McGeehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Upfront menin-inhibitor resistance in multiply pretreated leukemias 2025 ·Experimental Hematology ·(unknown), Fatemeh Alikarami‬, (unknown), (unknown), Simone S. Riedel, (unknown), (unknown), Sarah K. Tasian, (unknown), (unknown), Sarah Skuli, Martin Carroll, Gerald Wertheim, Sheng F. Cai, Gerard M. McGeehan, Sixiang Yu, Junwei Shi, Hongbo Xie, Kathrin M. Bernt	1
2	Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1 2023 ·Blood Cancer Journal ·Warren Fiskus, Christopher P. Mill, Christine Birdwell, John A. Davis, (unknown), Steffen Boettcher, Tapan M. Kadia, Courtney D. DiNardo, Koichi Takahashi, Sanam Loghavi, Michael Soth, Tim Heffernan, Gerard M. McGeehan, Xinjia Ruan, Xiaoping Su, Christopher R. Vakoc, Naval Daver, Kapil N. Bhalla	33
3	Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1 2023 ·Leukemia ·Christopher P. Mill, Warren Fiskus, (unknown), John A. Davis, Christine Birdwell, Tapan M. Kadia, Courtney D. DiNardo, Naval Daver, Koichi Takahashi, Koji Sasaki, Gerard M. McGeehan, Xinjia Ruan, Xiaoping Su, Sanam Loghavi, Hagop M. Kantarjian, Kapil N. Bhalla	6
4	The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML 2023 ·HemaSphere ·(unknown), Helen Blair, (unknown), Katarzyna Szołtysek, Rachel Cameron, (unknown), Anja Krippner‐Heidenreich, Florian Grebien, Gerard M. McGeehan, C. Michel Zwaan, Olaf Heidenreich	17
5	Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c) 2022 ·Blood Cancer Journal ·Warren Fiskus, Steffen Boettcher, Naval Daver, Christopher P. Mill, Koji Sasaki, Christine Birdwell, John A. Davis, Koichi Takahashi, Tapan M. Kadia, Courtney D. DiNardo, Qi Jin, Yuan Qi, Xiaoping Su, Gerard M. McGeehan, Joseph D. Khoury, Benjamin L. Ebert, Kapil N. Bhalla	73
6	Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia 2020 ·Science ·Hannah J. Uckelmann, (unknown), Eric Wong, Charlie Hatton, Hugh Giovinazzo, Jayant Y. Gadrey, Andrei V. Krivtsov, Frank G. Rücker, Konstanze Döhner, Gerard M. McGeehan, Ross L. Levine, Lars Bullinger, George S. Vassiliou, Scott A. Armstrong	152
7	Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis 2018 ·Annals of Allergy Asthma & Immunology ·Tali Czarnowicki, Anders B. Dohlman, Kunal Malik, (unknown), Robert Bissonnette, Tom C. Chan, Lisa Zhou, Huei‐Chi Wen, Yeriel Estrada, Hui Xu, (unknown), Jie Shen, Deepak S. Lala, Avi Ma’ayan, Gerard M. McGeehan, Richard E. Gregg, Emma Guttman‐Yassky	27
8	Regulation of Sphingomyelin Phosphodiesterase Acid-Like 3A Gene (SMPDL3A) by Liver X Receptors 2012 ·Molecular Pharmacology ·(unknown), Yuri Bukhtiyarov, Meng Shi, Brian M. McKeever, Gerard M. McGeehan, Deepak S. Lala	17
9	VTP-27999: A NOVEL RENIN INHIBITOR WITH POTENTIAL FOR SUPERIOR NEPHROPROTECTION 2011 ·Journal of Hypertension ·(unknown), Gerard M. McGeehan, (unknown), A.H. Jan Danser, David A. Claremon, J M Balcarek	2
10	Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293 2004 ·Protein Expression and Purification ·(unknown), Zhongren Wu, Boyd B. Scott, Gerard M. McGeehan, Richard K. Harrison	4
11	Method to analyze collagenase and gelatinase activity by fibroblasts in culture 1999 ·In Vitro Cellular & Developmental Biology - Animal ·Lisa J. Gould, Dorne R. Yager, Gerard M. McGeehan, Robert F. Diegelmann	1
12	Nanomolar Inhibitors for Two Distinct Biological Target Families from a Single Synthetic Sequence: A Next Step in Combinatorial Library Design? 1998 ·Angewandte Chemie International Edition ·Christopher J. Burns, Robert D. Groneberg, Joseph M. Salvino, Gerard M. McGeehan, Stephen M. Condon, Robert W. Morris, (unknown), Rose Mathew, (unknown), Kent Neuenschwander, (unknown), Stevan W. Djurić, (unknown), Richard Labaudinière	14
13	Structural features and biochemical properties of TNF-α converting enzyme (TACE) 1997 ·Journal of Neuroimmunology ·Marcia L. Moss, (unknown), J. David Becherer, D. Mark Bickett, William Burkhart, (unknown), Daniel F. Hassler, (unknown), Gerard M. McGeehan, Marcos E. Milla, Mary B. Moyer, Warren J. Rocque, Theresa Seaton, Frank J. Schoenen, Janet Warner, Derril H. Willard	86
14	Monoclonal Antibodies against Human Collagenase and Stromelysin 1995 ·Hybridoma ·Jui‐Lan Su, Johannes Becherer, Christine Edwards, (unknown), Gerard M. McGeehan, Brian Champion	5
15	[3] Defined substrate mixtures for mapping of proteinase specificities 1995 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Gerard M. McGeehan, D. Mark Bickett, Jeffrey S. Wiseman, Michael D. Green, Judd Berman	6
16	A High Throughput Fluorogenic Substrate for Stromelysin (MMP‐3) 1994 ·Annals of the New York Academy of Sciences ·D. Mark Bickett, Michael D. Green, Craig D. Wagner, (unknown), Judd Berman, Gerard M. McGeehan	12
17	Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor 1994 ·Nature ·Gerard M. McGeehan, J. David Becherer, Robert C. Bast, Cinda M. Boyer, Brian Champion, Kevin Connolly, James G. Conway, Paul J. Furdon, Stephen E. Karp, (unknown), Andrew B. McElroy, James Nichols, (unknown), Frank J. Schoenen, Les Sekut, Anne T. Truesdale, Margrith W. Verghese, Janet Warner, J P Ways	485
18	Structural Analysis of the Catalytic Domain of Human Fibroblast Collagenase 1994 ·Annals of the New York Academy of Sciences ·Brett Lovejoy, Anne Cleasby, Anne M. Hassell, Michael Luther, Debra Weigl, Gerard M. McGeehan, Millard H. Lambert, Steven R. Jordan	16
19	Metal ion stabilization of the conformation of a recombinant 19‐kDa catalytic fragment of human fibroblast collagenase 1992 ·Proteins Structure Function and Bioinformatics ·(unknown), Gerard M. McGeehan, (unknown)	42
20	The ribonuclease from an extinct bovid ruminant 1990 ·FEBS Letters ·Joseph Stackhouse, Scott Presnell, Gerard M. McGeehan, Krishnan P. Nambiar, Steven A. Benner	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact